These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3036457)

  • 1. [Acute reversible kidney insufficiency due to enalapril during diuretic-treated heart insufficiency].
    Degenhardt S
    Dtsch Med Wochenschr; 1987 Jun; 112(24):960-3. PubMed ID: 3036457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe complications during enalapril therapy for heart insufficiency].
    Wieland T; Stäubli M
    Schweiz Med Wochenschr; 1988 Dec; 118(48):1789-92. PubMed ID: 2849806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kidney insufficiency following use of enalapril for congestive heart failure].
    Botman CJ; Mulder AW; Hoorntje SJ
    Ned Tijdschr Geneeskd; 1987 Aug; 131(32):1402-4. PubMed ID: 2821411
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis.
    Thind GS
    J Clin Hypertens; 1985 Dec; 1(4):337-43. PubMed ID: 3014079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute renal failure caused by treatment with diuretics and ACE inhibitors in the absence of renal artery stenosis].
    Camaiti A; Del Rosso A; Federighi G
    Minerva Med; 1992 Jun; 83(6):371-5. PubMed ID: 1630698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction.
    Reams GP; Bauer JH
    Arch Intern Med; 1986 Nov; 146(11):2145-8. PubMed ID: 3022660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe electrolyte disorders during the therapy of heart failure with the therapy of heart failure with the ACE-inhibitor enalapril].
    Hess B; Keusch G; Neftel K; Margelist F; Bansky G
    Schweiz Med Wochenschr; 1986 Sep; 116(39):1331-6. PubMed ID: 3022372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure following massive mannitol infusion and enalapril treatment.
    Nakhoul F; Better OS
    Clin Nephrol; 1995 Aug; 44(2):118-20. PubMed ID: 8529299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reversible acute renal insufficiency caused by converting enzyme inhibitors in a patient with mesangial glomerulonephritis].
    Guérin C; Berthoux P; Berthoux FC
    Nephrologie; 1987; 8(6):307-8. PubMed ID: 2837670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible impairment of renal function associated with enalapril in a diabetic patient.
    Albareda MM; Corcoy R
    CMAJ; 1998 Nov; 159(10):1279-81. PubMed ID: 9861226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ACE-inhibition on renal function in severe congestive heart failure.
    Swedberg K
    Z Kardiol; 1991; 80 Suppl 2():50-4. PubMed ID: 2024543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of renal function in the transplanted patient with renal hypertension treated with enalapril].
    Guerin C; Genin C; Sabatier JC; Toulon J; Leroy G; Berthoux F
    Nephrologie; 1987; 8(1):19-22. PubMed ID: 3035397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and renal effects of enalapril in post-transplant hypertension.
    Hricik DE
    Clin Nephrol; 1987 May; 27(5):250-9. PubMed ID: 3036407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.